Oncology & Cancer

New platform optimizes selection of combination cancer therapies

Researchers at The University of Texas MD Anderson Cancer Center have developed a new bioinformatics platform that predicts optimal treatment combinations for a given group of patients based on co-occurring tumor alterations. ...

Genetics

'CYCLOPS' genes may serve as an Achilles' heel in tumor cells

BOSTON--The genomic tumult within tumor cells has provided scientists at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard with clues to an entirely new class of genes that may serve as an Achilles' ...

Medications

FDA approves personalized cellular therapy for advanced leukemia

In a landmark decision for the field of cancer immunotherapy, the U.S. Food and Drug Administration (FDA) today approved a personalized cellular therapy developed by the University of Pennsylvania and Children's Hospital ...

page 18 from 26